⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 15 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 52 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 15 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 52 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT July 14, 2026

Memantin ratiopharm GmbH 20 mg Filmtabletten 20 mg (Filmtablette)

📷 Wikipedia: Memantine · Source
Memantin ratiopharm GmbH 20 mg Filmtabletten 20 mg (Filmtablette)
📷 Wikipedia: Memantine · Source
Memantin ratiopharm GmbH 20 mg film-coated tablets are delayed. Affected packs: 28-tablet box, blister pack [unavailable since 13 July 2026]. 14-tablet box, blister pack remains available.
⚠️
Shortage ongoing
MEMANTIN HYDROCHLORID is currently in short supply in AT.
📈 Timeline
13 days active so far
July 15, 2026 July 27, 2026

What is this? Memantin is a medicine used for memory problems in conditions like Alzheimer’s disease. It comes as 20 mg tablets.

What's happening? Some packs of this medicine are not being delivered on time. Only the 14-tablet packs are still available.

Does this affect me? If you take the 28-tablet pack, you may have trouble getting your next supply.

What should I do? Ask your pharmacist or doctor for advice before running out of tablets.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
MEMANTIN HYDROCHLORID
Agency-published detail

ATC: N06DX01 · Reason: Verzögerung bei der Auslieferung · Marketing authorisation holder: Teva B.V., Swensweg 5, 2031 GA Haarlem, Niederlande · Affected packs: 28 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-07-13] · 14 Stück Schachtel, Blisterpackung [verfügbar]

First published
July 14, 2026
Last refreshed by us
16 hours ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

Medium AT resolved 3 months ago

Memantine Merz 10 mg Filmtabletten 10 mg (Filmtablette)

Memantine Merz 10 mg film-coated tablets are temporarily unavailable due to a manufacturing delay. The affected packs are the 28-tablet blister box.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Memantin ratiopharm GmbH 20 mg Filmtabletten 20 mg (Filmtablette). Memantin ratiopharm GmbH 20 mg film-coated tablets are delayed. Affected packs: 28-tablet box, blister pack [unavailable since 13 July 2026]. 14-tablet box, blister pack remains available.
▸ When was this alert issued?
This alert was issued on July 14, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.